DOWDEN NATHAN J (Chief Operating Officer) reported 1 transaction at ENTRADA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/4/2025ACC: 0001873392-25-000003
Officer· Chief Operating Officer
Since Oct 2021
-1.75K
Net shares
Net seller
$9.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.75K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.75K
Price / share
$5.43
Trade value
$9.48K
% of position
1.0%
9/2/2025
180.81K→179.06K
Total
Net shares
−1.75K
Net value
-$9.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2025 | F · Tax Withholding | −1.75K | $5.43 | $9.48K | 1.0% | 180.81K | 179.06K |
| Total | −1.75K | -$9.48K | ||||||
Derivative Transactions0
No derivative transactions reported